Journal
JOURNAL OF LIPID RESEARCH
Volume 58, Issue 3, Pages 481-493Publisher
ELSEVIER
DOI: 10.1194/jlr.O072629
Keywords
type 2 diabetes; cardiovascular risk factors; metabolic disease; coronary artery disease; METSIM
Categories
Funding
- National Institutes of Health
- Academy of Finland
- University of Eastern Finland
- Juselius Foundation
- Finnish Diabetes Research Foundation
- Finnish Foundation for Cardiovascular Research
Ask authors/readers for more resources
The Metabolic Syndrome in Men (METSIM) study is a population-based study including 10,197 Finnish men examined in 2005-2010. The aim of the study is to investigate nongenetic and genetic factors associated with the risk of T2D and CVD, and with cardiovascular risk factors. The protocol includes a detailed phenotyping of the participants, an oral glucose tolerance test, fasting laboratory measurements including proton NMR measurements, mass spectometry metabolomics, adipose tissue biopsies from 1,400 participants, and a stool sample. In our ongoing follow-up study, we have, to date, reexamined 6,496 participants. Extensive genotyping and exome sequencing have been performed for essentially all METSIM participants, and > 2,000 METSIM participants have been whole-genome sequenced. We have identified several nongenetic markers associated with the development of diabetes and cardiovascular events, and participated in several genetic association studies to identify gene variants associated with diabetes, hyperglycemia, and cardiovascular risk factors.jlr The generation of a phenotype and genotype resource in the METSIM study allows us to proceed toward a systems genetics approach, which includes statistical methods to quantitate and integrate intermediate phenotypes, such as transcript, protein, or metabolite levels, to provide a global view of the molecular architecture of complex traits.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available